Title 21, Part 866 — Immunology and Microbiology Devices
252 sections
Section 866.1
Scope.
Section 866.3
Effective dates of requirement for premarket approval.
Section 866.9
Limitations of exemptions from section 510(k) of the Federal Food, Drug, and Cosmetic Act (the act).
Section 866.1620
Antimicrobial susceptibility test disc.
Section 866.1640
Antimicrobial susceptibility test powder.
Section 866.1645
Fully automated short-term incubation cycle antimicrobial susceptibility system.
Section 866.1650
A cellular analysis system for multiplexed antimicrobial susceptibility testing.
Section 866.1655
System for detection of microorganisms and antimicrobial resistance using reporter expression.
Section 866.1700
Culture medium for antimicrobial susceptibility tests.
Section 866.2050
Staphylococcal typing bacteriophage.
Section 866.2120
Anaerobic chamber.
Section 866.2160
Coagulase plasma.
Section 866.2170
Automated colony counter.
Section 866.2180
Manual colony counter.
Section 866.2190
Automated image assessment system for microbial colonies on solid culture media.
Section 866.2300
Multipurpose culture medium.
Section 866.2320
Differential culture medium.
Section 866.2330
Enriched culture medium.
Section 866.2350
Microbiological assay culture medium.
Section 866.2360
Selective culture medium.
Section 866.2390
Transport culture medium.
Section 866.2410
Culture medium for pathogenic spp.
Section 866.2420
Oxidase screening test for gonorrhea.
Section 866.2440
Automated medium dispensing and stacking device.
Section 866.2450
Supplement for culture media.
Section 866.2480
Quality control kit for culture media.
Section 866.2500
Microtiter diluting and dispensing device.
Section 866.2540
Microbiological incubator.
Section 866.2560
Microbial growth monitor.
Section 866.2580
Gas-generating device.
Section 866.2600
Wood's fluorescent lamp.
Section 866.2660
Microorganism differentiation and identification device.
Section 866.2680
nucleic acid-based assay.
Section 866.2850
Automated zone reader.
Section 866.2900
Microbiological specimen collection and transport device.
Section 866.2950
Microbial nucleic acid storage and stabilization device.
Section 866.3010
serological reagents.
Section 866.3020
Adenovirus serological reagents.
Section 866.3035
spp. serological reagents.
Section 866.3040
spp. serological reagents.
Section 866.3045
In vitro diagnostic device for spp. detection.
Section 866.3050
Beta-glucan serological assays.
Section 866.3060
serological reagents.
Section 866.3065
spp. serological reagents.
Section 866.3085
spp. serological reagents.
Section 866.3110
serological reagents.
Section 866.3120
Chlamydia serological reagents.
Section 866.3125
spp. serological reagents.
Section 866.3130
Clostridium difficile toxin gene amplification assay.
Section 866.3135
serological reagents.
Section 866.3140
spp. serological reagents.
Section 866.3145
Coxsackievirus serological reagents.
Section 866.3165
serological reagents.
Section 866.3169
Hepatitis C virus antibody tests.
Section 866.3170
Nucleic acid-based hepatitis C virus ribonucleic acid tests.
Section 866.3172
Qualitative hepatitis B virus antigen assays.
Section 866.3173
Hepatitis B virus antibody assays.
Section 866.3174
Hepatitis B virus nucleic acid-based assays.
Section 866.3175
Cytomegalovirus serological reagents.
Section 866.3180
Quantitative cytomegalovirus nucleic acid tests for transplant patient management.
Section 866.3181
Cytomegalovirus nucleic acid detection device for congenital cytomegalovirus infection.
Section 866.3183
Quantitative viral nucleic acid test for transplant patient management.
Section 866.3200
spp. serological reagents.
Section 866.3205
Echovirus serological reagents.
Section 866.3210
Endotoxin assay.
Section 866.3215
Device to detect and measure non-microbial analyte(s) in human clinical specimens to aid in assessment of patients with suspected sepsis.
Section 866.3220
serological reagents.
Section 866.3225
Enterovirus nucleic acid assay.
Section 866.3230
Device to detect and measure non-microbial analytes to aid in the detection and identification of localized human infections.
Section 866.3231
Device to detect bacterial protease activity in chronic wound fluid.
Section 866.3235
Epstein-Barr virus serological reagents.
Section 866.3236
Device to detect or measure nucleic acid from viruses associated with head and neck cancers.
Section 866.3240
Equine encephalomyelitis virus serological reagents.
Section 866.3250
serological reagents.
Section 866.3255
serological reagents.
Section 866.3270
spp. serological reagents.
Section 866.3280
serological reagents.
Section 866.3290
Gonococcal antibody test (GAT).
Section 866.3300
spp. serological reagents.
Section 866.3305
Herpes simplex virus serological assays.
Section 866.3307
Herpes simplex virus nucleic acid-based assay for central nervous system infections.
Section 866.3309
Herpes virus nucleic acid-based cutaneous and mucocutaneous lesion panel.
Section 866.3310
Hepatitis A virus (HAV) serological assays.
Section 866.3320
serological reagents.
Section 866.3328
Influenza virus antigen detection test system.
Section 866.3330
Influenza virus serological reagents.
Section 866.3332
Reagents for detection of specific novel influenza A viruses.
Section 866.3336
John Cunningham Virus serological reagents.
Section 866.3340
spp. serological reagents.
Section 866.3350
spp. serological reagents.
Section 866.3355
spp. serological reagents.
Section 866.3360
Lymphocytic choriomeningitis virus serological reagents.
Section 866.3361
Mass spectrometer system for clinical use for the identification of microorganisms.
Section 866.3365
Multiplex nucleic acid assay for identification of microorganisms and resistance markers from positive blood cultures.
Section 866.3367
Device to detect and identify microbial nucleic acids by FISH in clinical specimens.
Section 866.3370
immunofluorescent reagents.
Section 866.3372
Nucleic acid-based in vitro diagnostic devices for the detection of Mycobacterium tuberculosis complex in respiratory specimens.
Section 866.3373
Nucleic acid-based in vitro diagnostic devices for the detection of Mycobacterium tuberculosis complex (MTB-complex) and the genetic mutations associated with MTB-complex antibiotic resistance in respiratory specimens.
Section 866.3375
spp. serological reagents.
Section 866.3376
Device to detect and identify fungal nucleic acids directly in respiratory specimens.
Section 866.3378
Clinical mass spectrometry microorganism identification and differentiation system.
Section 866.3380
Mumps virus serological reagents.
Section 866.3390
spp. direct serological test reagents.
Section 866.3393
Device to detect nucleic acids from non-viral microorganism(s) causing sexually transmitted infections and associated resistance marker(s).
Section 866.3395
Norovirus serological reagents.
Section 866.3400
Parainfluenza virus serological reagents.
Section 866.3402
Plasmodium species antigen detection assays.
Section 866.3405
Poliovirus serological reagents.
Section 866.3410
spp. (Weil-Felix) serological reagents.
Section 866.3415
spp. serological reagents.
Section 866.3460
Rabiesvirus immunofluorescent reagents.
Section 866.3470
Reovirus serological reagents.
Section 866.3480
Respiratory syncytial virus serological reagents.
Section 866.3490
Rhinovirus serological reagents.
Section 866.3500
Rickettsia serological reagents.
Section 866.3510
Rubella virus serological reagents.
Section 866.3520
Rubeola (measles) virus serological reagents.
Section 866.3550
spp. serological reagents.
Section 866.3600
spp. serological reagents.
Section 866.3630
spp. serological reagents.
Section 866.3660
spp. serological reagents.
Section 866.3680
serological reagents.
Section 866.3700
serological reagents.
Section 866.3720
spp. exoenzyme reagents.
Section 866.3740
spp. serological reagents.
Section 866.3780
serological reagents.
Section 866.3820
nontreponemal test reagents.
Section 866.3830
treponemal test reagents.
Section 866.3850
serological reagents.
Section 866.3860
nucleic acid assay.
Section 866.3870
spp. serological reagents.
Section 866.3900
Varicella-zoster virus serological reagents.
Section 866.3920
Assayed quality control material for clinical microbiology assays.
Section 866.3930
serological reagents.
Section 866.3935
Zika virus serological reagents.
Section 866.3940
West Nile virus serological reagents.
Section 866.3945
Dengue virus serological reagents.
Section 866.3946
Dengue virus nucleic acid amplification test reagents.
Section 866.3950
In vitro human immunodeficiency virus (HIV) drug resistance genotype assay.
Section 866.3955
Human immunodeficiency virus (HIV) drug resistance genotyping assay using next generation sequencing technology.
Section 866.3956
Human immunodeficiency virus (HIV) serological diagnostic and/or supplemental test.
Section 866.3957
Human immunodeficiency virus (HIV) nucleic acid (NAT) diagnostic and/or supplemental test.
Section 866.3958
Human immunodeficiency virus (HIV) viral load monitoring test.
Section 866.3960
Nucleic acid-based device for the amplification, detection, and identification of microbial pathogens directly from whole blood specimens.
Section 866.3966
Device to detect and identify selected microbial agents that cause acute febrile illness.
Section 866.3970
Device to detect and identify microbial pathogen nucleic acids in cerebrospinal fluid.
Section 866.3975
Device that detects nucleic acid sequences from microorganisms associated with vaginitis and bacterial vaginosis.
Section 866.3980
Respiratory viral panel multiplex nucleic acid assay.
Section 866.3981
Device to detect and identify nucleic acid targets in respiratory specimens from microbial agents that cause the SARS-CoV-2 respiratory infection and other microbial agents when in a multi-target test.
Section 866.3985
Device to detect and identify microorganisms and associated resistance marker nucleic acids directly in respiratory specimens.
Section 866.3990
Gastrointestinal microorganism multiplex nucleic acid-based assay.
Section 866.4001
A multiplex respiratory panel to detect and identify emerging respiratory pathogen(s) and common respiratory pathogens in human clinical specimens.
Section 866.4070
RNA Preanalytical Systems.
Section 866.4100
Complement reagent.
Section 866.4500
Immunoelectrophoresis equipment.
Section 866.4520
Immunofluorometer equipment.
Section 866.4540
Immunonephelometer equipment.
Section 866.4600
Ouchterlony agar plate.
Section 866.4700
Automated fluorescence hybridization (FISH) enumeration systems.
Section 866.4750
Automated indirect immunofluorescence microscope and software-assisted system.
Section 866.4800
Radial immunodiffusion plate.
Section 866.4830
Rocket immunoelectrophoresis equipment.
Section 866.4900
Support gel.
Section 866.5040
Albumin immunological test system.
Section 866.5060
Prealbumin immunological test system.
Section 866.5065
Human allotypic marker immunological test system.
Section 866.5080
-1-antichymotrypsin immunological test system.
Section 866.5090
Antimitochondrial antibody immunological test system.
Section 866.5100
Antinuclear antibody immunological test system.
Section 866.5110
Antiparietal antibody immunological test system.
Section 866.5120
Antismooth muscle antibody immunological test system.
Section 866.5130
-1-antitrypsin immunological test system.
Section 866.5150
Bence-Jones proteins immunological test system.
Section 866.5160
-globulin immunological test system.
Section 866.5170
Breast milk immunological test system.
Section 866.5180
Fecal calprotectin immunological test system.
Section 866.5200
Carbonic anhydrase B and C immunological test system.
Section 866.5210
Ceruloplasmin immunological test system.
Section 866.5220
Cohn fraction II immunological test system.
Section 866.5230
Colostrum immunological test system.
Section 866.5240
Complement components immunological test system.
Section 866.5250
Complement C inhibitor (inactivator) immunological test system.
Section 866.5260
Complement C inactivator immunological test system.
Section 866.5270
C-reactive protein immunological test system.
Section 866.5320
Properdin factor B immunological test system.
Section 866.5330
Factor XIII, A, S, immunological test system.
Section 866.5340
Ferritin immunological test system.
Section 866.5350
Fibrinopeptide A immunological test system.
Section 866.5360
Cohn fraction IV immunological test system.
Section 866.5370
Cohn fraction V immunological test system.
Section 866.5380
Free secretory component immunological test system.
Section 866.5400
-globulin immunological test system.
Section 866.5420
-1-glycoproteins immunological test system.
Section 866.5425
-2-glycoproteins immunological test system.
Section 866.5430
-2-glycoprotein I immunological test system.
Section 866.5440
-2-glycoprotein III immunological test system.
Section 866.5460
Haptoglobin immunological test system.
Section 866.5470
Hemoglobin immunological test system.
Section 866.5490
Hemopexin immunological test system.
Section 866.5500
Hypersensitivity pneumonitis immunological test system.
Section 866.5510
Immunoglobulins A, G, M, D, and E immunological test system.
Section 866.5520
Immunoglobulin G (Fab fragment specific) immunological test system.
Section 866.5530
Immunoglobulin G (Fc fragment specific) immunological test system.
Section 866.5540
Immunoglobulin G (Fd fragment specific) immunological test system.
Section 866.5550
Immunoglobulin (light chain specific) immunological test system.
Section 866.5560
Lactic dehydrogenase immunological test system.
Section 866.5570
Lactoferrin immunological test system.
Section 866.5580
-1-lipoprotein immunological test system.
Section 866.5590
Lipoprotein X immunological test system.
Section 866.5600
Low-density lipoprotein immunological test system.
Section 866.5620
-2-macroglobulin immunological test system.
Section 866.5630
-2-microglobulin immunological test system.
Section 866.5640
Infectious mononucleosis immunological test system.
Section 866.5660
Multiple autoantibodies immunological test system.
Section 866.5665
Aquaporin-4 autoantibody immunological test system.
Section 866.5670
Zinc transporter 8 autoantibody immunological test system.
Section 866.5680
Myoglobin immunological test system.
Section 866.5700
Whole human plasma or serum immunological test system.
Section 866.5715
Plasminogen immunological test system.
Section 866.5735
Prothrombin immunological test system.
Section 866.5750
Radioallergosorbent (RAST) immunological test system.
Section 866.5760
Tryptase test system.
Section 866.5765
Retinol-binding protein immunological test system.
Section 866.5775
Rheumatoid factor immunological test system.
Section 866.5780
Anti-phospholipase A2 receptor immunological test system.
Section 866.5785
Anti- () antibody (ASCA) test systems.
Section 866.5800
Seminal fluid (sperm) immunological test system.
Section 866.5820
Systemic lupus erythematosus immunological test system.
Section 866.5830
Brain trauma assessment test.
Section 866.5860
Total spinal fluid immunological test system.
Section 866.5870
Thyroid autoantibody immunological test system.
Section 866.5880
Transferrin immunological test system.
Section 866.5890
Inter- trypsin inhibitor immunological test system.
Section 866.5900
Cystic fibrosis transmembrane conductance regulator (CFTR) gene mutation detection system.
Section 866.5910
Quality control material for cystic fibrosis nucleic acid assays.
Section 866.5920
Postnatal chromosomal copy number variation detection system.
Section 866.5930
Newborn screening test for severe combined immunodeficiency disorder (SCID).
Section 866.5940
Autosomal recessive carrier screening gene mutation detection system.
Section 866.5950
Genetic health risk assessment system.
Section 866.5960
Human leukocyte antigen typing companion diagnostic test.
Section 866.5970
Inherited nucleotide repeat disorder DNA test.
Section 866.6000
Whole exome sequencing constituent device.
Section 866.6010
Tumor-associated antigen immunological test system.
Section 866.6020
Immunomagnetic circulating cancer cell selection and enumeration system.
Section 866.6030
AFP-L3% immunological test system.
Section 866.6040
Gene expression profiling test system for breast cancer prognosis.
Section 866.6050
Ovarian adnexal mass assessment score test system.
Section 866.6060
BCR-ABL quantitation test.
Section 866.6070
Mutation detection test for myeloproliferative neoplasms.
Section 866.6080
Next generation sequencing based tumor profiling test.
Section 866.6090
Cancer predisposition risk assessment system.
Section 866.6100
DNA-based test to measure minimal residual disease in hematological malignancies.